Botanical species · safety record

Plantago major

The EFSA Compendium of Botanicals holds 2 constituent measurements, 1 adverse-effect record and 1 genotoxicity assay for Plantago major. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Plantago major L.

2Constituent measurements
2Safety records
3Cited sources
161Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 161 licensed products naming Plantago major as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Fresh

Source material stated

  • Aerial parts
  • Fresh aerial part
  • Fresh aerial parts
  • Fresh whole flowering plant
  • Fruit
  • Grass(es)
  • Herb
  • Leaf

What the records describe

Constituents measured

  • Erucic acid1
  • Oxalates1

Plant parts

  • Leaves3

Preparations

  • Solvent extraction3

Effect types

  • Other toxicities1

Target tissues

  • Neurologic: central nervous system1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Erucic acidLeavesSolvent extraction3.45 PercentGaschromatography (GC)Resolve DOI
OxalatesLeavesSolvent extraction0.67 Milligram/100 gramColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
Other toxicitiesNeurologic: central nervous systemLeavesSolvent extractionRat (as animal)SubchronicNo resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

OutcomeEndpointTestTested organismMetabolic activationSource
Positivegenome mutationsomatic mutation assay in DrosophilaDrosophila melanogaster (as animal)Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Guil, JL., Rodriguez-Garcia, I., Torija, E. Nutritional and toxic factors in selected wild edible plants. PLANT FOODS FOR HUMAN NUTRITION, 1997, vol. 51, no. 2, p. 99-107. DOI
  2. Pimenta, VMSD., Nepomuceno, JC. Genotoxicity testing of Plantago major extracts in somatic cells of Drosophila melanogaster . Environmental and molecular mutagenesis, 2005, vol. 45, no. 1, p. 56-61. DOI
  3. Gonzalez, MG., Coto-Morales, T., Rodriguez, GAS., Pazos, L. Sub-chronic toxicity and test of eye irritability of leaf aqueous extract from Plantago major (Plantaginaceae) . Revista de biologia tropical, 2003, vol. 51, no. 3-4, p. 635-638.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue